These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3898826)
1. Potassium supplementation via the dialysate in continuous ambulatory peritoneal dialysis. Spital A; Sterns RH Am J Kidney Dis; 1985 Sep; 6(3):173-6. PubMed ID: 3898826 [TBL] [Abstract][Full Text] [Related]
2. A quantitative description of solute and fluid transport during peritoneal dialysis. Heimbürger O; Waniewski J; Werynski A; Lindholm B Kidney Int; 1992 May; 41(5):1320-32. PubMed ID: 1614047 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Icodextrin and 2.5% Glucose in Potassium Metabolism by Acute K load via Dialysate in Continuous Ambulatory Peritoneal Dialysis Patients. Yi JH; Yun YW; Han SW; Kim HJ Electrolyte Blood Press; 2009 Jun; 7(1):25-30. PubMed ID: 21468182 [TBL] [Abstract][Full Text] [Related]
11. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group. Weinreich T; Passlick-Deetjen J; Ritz E Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324 [TBL] [Abstract][Full Text] [Related]
12. Intra-peritoneal administration of potassium and magnesium: a practical method to supplement these electrolytes in peritoneal dialysis patients. Amirmokri P; Morgan P; Bastani B Ren Fail; 2007; 29(5):603-5. PubMed ID: 17654324 [TBL] [Abstract][Full Text] [Related]
14. Effect of peritoneal glucose load on plasma leptin concentration in continuous ambulatory peritoneal dialysis patients. Kim MJ; Kim GA; Lee SW; Song JH; Hyun IY Yonsei Med J; 2000 Aug; 41(4):485-90. PubMed ID: 10992810 [TBL] [Abstract][Full Text] [Related]
15. Low sodium concentration solution in normohydrated CAPD patients. Amici G; Virga G; Da Rin G; Teodori T; Calzavara P; Bocci C Adv Perit Dial; 1995; 11():78-82. PubMed ID: 8534744 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis. Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432 [TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis. Fleming LW; Moreland TA; Scott AC; Stewart WK; White LO J Antimicrob Chemother; 1987 Apr; 19(4):493-503. PubMed ID: 3583969 [TBL] [Abstract][Full Text] [Related]
18. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088 [TBL] [Abstract][Full Text] [Related]
19. Abdominal pains during CAPD with acetate buffered dialysate. Ahlmén J; Stelin G Lancet; 1983 Nov; 2(8361):1247. PubMed ID: 6139586 [No Abstract] [Full Text] [Related]
20. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD. Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]